NCT06913595View on ClinicalTrials.gov

Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

October 25, 2025

Study Completion Date

November 1, 2025

Conditions
Deep Venous Thrombosis
Interventions
DRUG

Direct Oral Anticoagulant.

Direct Oral Anticoagulant AFTER BARIATRIC SURGERY

DRUG

Low Molecular Weight Heparine

Low molecular weight heparin after bariatric surgery

Trial Locations (1)

11511

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT06913595 - Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery | Biotech Hunter | Biotech Hunter